Hugh Watson is a clinical researcher in infectious diseases at Evotec in Lyon. His broad experience in clinical drug development is currently being applied to improving our understanding of chronic chikungunya disease and developing evidence-based clinical trial designs for future interventions.
Hugh Watson is a clinical researcher in infectious diseases at Evotec in Lyon. His broad experience in clinical drug development is currently being applied to improving our understanding of chronic chikungunya disease and developing evidence-based clinical trial designs for future interventions.